Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Ethical considerations in tissue engineering research: Case studies in translation.

Baker HB, McQuilling JP, King NM.

Methods. 2016 Apr 15;99:135-44. doi: 10.1016/j.ymeth.2015.08.010. Epub 2015 Aug 14. Review.

PMID:
26282436
2.

"It is not guaranteed that you will benefit": True but misleading?

Kim SY, Wilson R, De Vries R, Kim HM, Holloway RG, Kieburtz K.

Clin Trials. 2015 Aug;12(4):424-9. doi: 10.1177/1740774515585120. Epub 2015 May 11.

PMID:
25963311
3.

Clinical research and medical care: towards effective and complete integration.

Sacristán JA.

BMC Med Res Methodol. 2015 Jan 9;15:4. doi: 10.1186/1471-2288-15-4.

4.

The ethics of HIV "cure" research: what can we learn from consent forms?

Henderson GE.

AIDS Res Hum Retroviruses. 2015 Jan;31(1):56-63. doi: 10.1089/AID.2014.0219.

5.

An Empirical Ethics Agenda for Psychiatric Research Involving Prisoners.

Christopher PP, Candilis PJ, Rich JD, Lidz CW.

AJOB Prim Res. 2011;2(4):18-25.

6.

Cell-based interventions in utero: time to reconsider.

King NM, Iltis AS.

Front Pharmacol. 2014 Sep 17;5:214. doi: 10.3389/fphar.2014.00214. eCollection 2014. No abstract available.

7.

Ethical issues in stem cell research and therapy.

King NM, Perrin J.

Stem Cell Res Ther. 2014 Jul 7;5(4):85. doi: 10.1186/scrt474. Review.

8.

Quality improvement ethics: lessons from the SUPPORT study.

Wilfond BS.

Am J Bioeth. 2013;13(12):14-9. doi: 10.1080/15265161.2013.851582.

9.

What research ethics should learn from genomics and society research: lessons from the ELSI Congress of 2011.

Henderson GE, Juengst ET, King NM, Kuczynski K, Michie M.

J Law Med Ethics. 2012 Winter;40(4):1008-24. doi: 10.1111/j.1748-720X.2012.00728.x.

10.

Specimen collection for induced pluripotent stem cell research: harmonizing the approach to informed consent.

Lowenthal J, Lipnick S, Rao M, Hull SC.

Stem Cells Transl Med. 2012 May;1(5):409-21. doi: 10.5966/sctm.2012-0029. Epub 2012 May 8.

11.

Research participants' high expectations of benefit in early-phase oncology trials: are we asking the right question?

Weinfurt KP, Seils DM, Lin L, Sulmasy DP, Astrow AB, Hurwitz HI, Cohen RB, Meropol NJ.

J Clin Oncol. 2012 Dec 10;30(35):4396-400. doi: 10.1200/JCO.2011.40.6587. Epub 2012 Oct 22.

12.

Novel therapies, high-risk pediatric research, and the prospect of benefit: learning from the ethical disagreements.

de Melo-Martín I, Sondhi D, Crystal RG.

Mol Ther. 2012 Jun;20(6):1095-102. doi: 10.1038/mt.2012.90. No abstract available.

13.

Challenges in vector and trial design using retroviral vectors for long-term gene correction in hematopoietic stem cell gene therapy.

Corrigan-Curay J, Cohen-Haguenauer O, O'Reilly M, Ross SR, Fan H, Rosenberg N, Somia N, King N, Friedmann T, Dunbar C, Aiuti A, Naldini L, Baum C, von Kalle C, Kiem HP, Montini E, Bushman F, Sorrentino BP, Carrondo M, Malech H, Gahrton G, Shapiro R, Wolff L, Rosenthal E, Jambou R, Zaia J, Kohn DB.

Mol Ther. 2012 Jun;20(6):1084-94. doi: 10.1038/mt.2012.93. No abstract available.

14.

"If I could in a small way help": motivations for and beliefs about sample donation for genetic research.

Michie M, Henderson G, Garrett J, Corbie-Smith G.

J Empir Res Hum Res Ethics. 2011 Jun;6(2):57-70. doi: 10.1525/jer.2011.6.2.57.

15.

Accepting risk in clinical research: is the gene therapy field becoming too risk-averse?

Deakin CT, Alexander IE, Kerridge I.

Mol Ther. 2009 Nov;17(11):1842-8. doi: 10.1038/mt.2009.223. Epub 2009 Sep 22. Review.

16.

First-in-human trial participants: not a vulnerable population, but vulnerable nonetheless.

Dresser R.

J Law Med Ethics. 2009 Spring;37(1):38-50. doi: 10.1111/j.1748-720X.2009.00349.x.

17.

Expectations of benefit in early-phase clinical trials: implications for assessing the adequacy of informed consent.

Weinfurt KP, Seils DM, Tzeng JP, Compton KL, Sulmasy DP, Astrow AB, Solarino NA, Schulman KA, Meropol NJ.

Med Decis Making. 2008 Jul-Aug;28(4):575-81. doi: 10.1177/0272989X08315242. Epub 2008 Mar 31.

18.

Clinical trials and medical care: defining the therapeutic misconception.

Henderson GE, Churchill LR, Davis AM, Easter MM, Grady C, Joffe S, Kass N, King NM, Lidz CW, Miller FG, Nelson DK, Peppercorn J, Rothschild BB, Sankar P, Wilfond BS, Zimmer CR.

PLoS Med. 2007 Nov 27;4(11):e324. No abstract available.

19.

Views of people with schizophrenia regarding aspects of research: study size and funding sources.

Roberts LW, Warner TD, Hammond KG, Hoop JG.

Schizophr Bull. 2006 Jan;32(1):107-15. Epub 2005 Oct 27.

Items per page

Supplemental Content

Write to the Help Desk